Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study
Journal of Viral Hepatitis · 2025
DOI: 10.1111/jvh.70006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von ChulHyoung Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Chronic, alpha-Fetoproteins, Liver Neoplasms. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.
Abstract (Originalsprache)
Alpha‐fetoprotein (AFP) level and its changes in chronic hepatitis B (CHB) may influence the risk of future hepatocellular carcinoma (HCC). This study aims to evaluate the HCC risk in CHB patients with no overt HCC but with elevated AFP level and to explore the prognostic role of longitudinal changes in AFP and liver‐related laboratory values. This multicentre cohort study included 10,639 CHB patients without a history of HCC from seven medical facilities in South Korea. Patients with a baseline serum AFP test and no HCC diagnosis on imaging within 3 months were included. Patients were categorised into high‐AFP (≥ 10 ng/mL) and normal‐AFP (< 10 ng/mL) groups. The primary outcome was the incidence of HCC within 2 years, with secondary outcomes focused on longitudinal changes in AFP and liver‐related laboratory values. Propensity score matching (PSM) and Cox proportional hazard models were used to assess HCC risk. After 1:4 PSM, 1278 high‐AFP and 3731 normal‐AFP patients were analysed. The high‐AFP group had a significantly higher 2‐year incidence of HCC (HR: 4.29; 95% CI: 3.31–5.57). AFP levels increased in patients who developed HCC in both groups ( p < 0.01). Among the high‐AFP group, patients who did not develop HCC had elevated baseline alanine aminotransferase levels ( p < 0.01), which decreased during follow‐up ( p < 0.01) unlike those who developed HCC. In conclusion, baseline AFP elevation in CHB patients is associated with an increased risk of developing HCC within 2 years. Longitudinal monitoring of AFP and liver‐related laboratory values can help in risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.
- Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Gastroenterology, Ajou University School of Medicine, Suwon, Republic of Korea.
- Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, USA.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Subin Heo
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Park, C., Hwang, G., Choi, W. M., Han, J. E., Kim, C., Lee, D. Y., Heo, S., & Park, R. W. (2025). Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70006
Vancouver
Park C, Hwang G, Choi WM, Han JE, Kim C, Lee DY, et al. Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70006
BibTeX
@article{Park2025,
author = {Park, ChulHyoung and Hwang, Gyubeom and Choi, Won-Mook and Han, Ji Eun and Kim, Chungsoo and Lee, Dong Yun and Heo, Subin and Park, Rae Woong},
title = {Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study},
journal = {Journal of Viral Hepatitis},
year = {2025},
doi = {10.1111/jvh.70006}
}
EUVIMED